Trial intelligence / Profile preview

Magnesium for Postoperative Pain Control Following Periacetabular Osteotomy

NCT05947760Phase 4Completed

Sponsor
University Hospitals Cleveland Medical Center
Start
Mar 2025
Primary completion
Sep 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of magnesium sulfate in postoperative pain (2 arms), sponsored by University Hospitals Cleveland Medical Center. Primary endpoints: Visual Analog Scale at 7 days and Number of narcotic medications consumed at 7 days. Started Mar 2025; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05947760.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05947760.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call